Surgeon volume and 30 day mortality for brain tumours in England. - Wikidata - awgldk - TriplyDB

Surgeon volume and 30 day mortality for brain tumours in England.

Surgeon volume and 30 day mortality for brain tumours in England.

http://www.wikidata.org/entity/Q37457216

about

Surgeon volume and 30 day mortality for brain tumours in England.

http://www.wikidata.org/entity/Q37457216

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Surgeon volume and 30 day mortality for brain tumours in England.

@en

Surgeon volume and 30 day mortality for brain tumours in England.

@nl

type

label

Surgeon volume and 30 day mortality for brain tumours in England.

@en

Surgeon volume and 30 day mortality for brain tumours in England.

@nl

prefLabel

Surgeon volume and 30 day mortality for brain tumours in England.

@en

Surgeon volume and 30 day mortality for brain tumours in England.

@nl

P1433

Q37457216-E0073C86-6B80-4693-850E-72C267B0E9BE

P1476

Q37457216-49CC853F-7039-492E-BDE6-C9DB40594113

P2093

Q37457216-1CD83B21-3A08-4DB4-A0B6-A701CDE9DBF0

Q37457216-4474DCA3-D9A5-45B7-826A-4904C63EEF74

Q37457216-55506D8F-A77C-462A-9C27-C6BE004A59BD

Q37457216-7B6A900A-8723-46FD-A2EC-CC5937F41E56

Q37457216-CD3632A0-74F0-4CED-917A-19D25AD2F488

P2860

Q37457216-0114B3CA-3BBA-4862-9312-ABBF81460A4C

Q37457216-0A3CFE94-3C63-42C7-BAF6-66C75E278CB8

Q37457216-24CB8F45-5FA8-49AC-B401-334A16ABB6CF

Q37457216-2D26ACAF-F5C6-4317-A943-1768321F6AC9

Q37457216-43A3D452-C01C-4192-85DC-52F54011263B

Q37457216-484BA8DC-D733-4B49-A0F2-6938BF7293B9

Q37457216-717F13CA-69C4-4319-B134-AFD228F9E981

Q37457216-7B9B952F-46E6-4878-8C88-31DA68DBCEB6

Q37457216-7EB96CA3-A8C0-49BA-9790-18D461ED4C45

Q37457216-B2550304-3843-43AE-95A4-01F4077FEA67

P2888

Q37457216-62B9F0CF-B74C-464A-9CCC-A99D5964AAFE

P304

Q37457216-D60FF351-243E-4D7C-9FB5-943BE42A85F9

P31

Q37457216-CEBF55C4-E61E-4BCA-8E95-96187429A6E5

P356

Q37457216-E93C52D6-70C5-486F-83C8-E189B419DD57

P407

Q37457216-CA2C353B-D30E-4658-826B-4B0C4120739A

P433

Q37457216-170A5EB6-317C-493A-B636-78B79368B680

P478

Q37457216-EA7F85B8-43CC-444A-B55D-50457BED3D74

P577

Q37457216-D292D8CA-52AC-4104-87EF-587AF4948DF8

P6179

Q37457216-A00B1929-6F78-4EA9-9605-264C9A17DBC2

P698

Q37457216-C7830145-47BA-4FB0-AC95-5FAC46A2BAB2

P932

Q37457216-FE8C653A-CF4D-4E50-BCD4-EF254D90C778

P356

P1433

British Journal of Cancer

P1476

Surgeon volume and 30 day mortality for brain tumours in England.

@en

P2093

Andrew Brodbelt

http://www.w3.org/2001/XMLSchema#string

David Greenberg

http://www.w3.org/2001/XMLSchema#string

Matt Williams

http://www.w3.org/2001/XMLSchema#string

Peter Collins

http://www.w3.org/2001/XMLSchema#string

Peter Treasure

http://www.w3.org/2001/XMLSchema#string

P2860

Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

[Volume and health outcomes: an overview of systematic reviews].

The impact of provider volume on mortality after intracranial tumor resection.

Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers.

Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care.

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.

A systematic review of the impact of volume of surgery and specialization on patient outcome.

Surgery for primary supratentorial brain tumors in the United States, 2000-2009: effect of provider and hospital caseload on complication rates.

Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.

P2888

P304

1379-1382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.317

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013311495

http://www.w3.org/2001/XMLSchema#string

P698

27764843

http://www.w3.org/2001/XMLSchema#string

P932

5129829

http://www.w3.org/2001/XMLSchema#string